ProGnosis Biotech Advances Preventive Food Safety Approach at GFSI 2026

Company highlights next-generation testing solutions for food allergens, hygiene monitoring and mycotoxin detection, aligned with the industry’s shift toward prevention, resilience and stronger consumer trust

ProGnosis Biotech successfully participated in the GFSI Conference 2026, taking place in Vancouver, Canada, from March 24 to 26, 2026, joining leading stakeholders from across the global food industry in one of the sector’s most important annual gatherings. With this year’s conference centered on the theme “Food Safety is Everybody’s Business,” the event provided an important platform for dialogue, collaboration and exchange around the future of food safety.

At this year’s conference, ProGnosis Biotech presented two core segments of its portfolio, food safety and hygiene monitoring, demonstrating its commitment to delivering solutions that address the industry’s most pressing operational and regulatory needs.

Within the food safety pillar, ProGnosis Biotech brought allergen control to the forefront of its product offering, emphasising the role of rapid and reliable testing in helping food businesses make faster on-site decisions, strengthen compliance confidence and reduce operational risk across increasingly complex production environments. With allergen management becoming ever more critical across the food chain, the company highlighted testing technologies designed not only to deliver dependable results, but also to support more responsive decision-making in routine quality control.

The company also highlighted key food safety applications for the identification of Aflatoxin M1 and Aflatoxin B1, demonstrating how high-performance screening tools can help producers and quality teams act earlier, improve consistency in everyday testing and reinforce confidence in product integrity. Through its Bio-Shield (ELISA) and Symmetric (Lateral Flow) lines, ProGnosis Biotech presented a flexible product portfolio that allows customers to balance speed, sensitivity and operational practicality according to their specific workflow requirements.

Within the hygiene monitoring pillar, the company showcased a dedicated range of rapid testing technologies, including ATP-Flow Surface, ATP-Flow Total (Water ATP Test), ATP-Femto FLOW and Protein Flow, developed to help businesses verify hygiene status more efficiently, respond faster to potential issues and strengthen day-to-day control across demanding production environments. By supporting surface cleanliness checks, water testing and protein residue detection, these product lines help quality teams reduce operational uncertainty, reinforce preventive action and maintain greater confidence in hygiene monitoring processes.Top of FormBottom of Form

GFSI 2026 underscored the trends currently transforming global food safety with discussions centered on operational excellence, preventive risk management, advanced technology, supply chain resilience, data and food safety culture. Over the course of the three-day conference, the overall direction was clear: the industry is steadily moving away from reactive approaches and toward preventive action.

“Participating in GFSI 2026 reinforced our belief that the future of food safety is preventive, data-driven and operationally focused,” said Antonis Ntantasios, CEO and Co-Founder of ProGnosis Biotech. “Across the industry, we see an increasing demand for product technologies that enable faster, more confident decisions at every stage of the supply chain. At ProGnosis Biotech, we deliver technologies that not only meet these needs but also support a stronger culture of food safety, helping businesses act proactively, maintain consistency and protect consumers with measurable impact”.

Through its presence at GFSI 2026, ProGnosis Biotech underscored its commitment to advancing preventive food safety through high-value testing technologies that enable faster decisions, stronger control and greater confidence across the food chain. The conference served as an important platform to strengthen the company’s international visibility, deepen industry engagement and reinforce its role in shaping a more proactive and resilient future for food safety.

Share This Post

More To Explore

ProGnosis Biotech at WHX Labs Dubai 2026

ProGnosis Biotech participation at WHX Labs Dubai 2026 focused on practical systems that support efficient daily workflows, with an emphasis on ATP hygiene monitoring for

Want Exclusive Updates?

Sign up today to access the newest innovations tailored to your diagnostic needs